NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-009-1996-0-AU-03 METHODS AND COMPOSITIONS FOR INHIBITING INFLAMMATION AND ANGIOGENESIS AU National Stage 51580/98 Abandoned
NCI E-009-1996-0-JP-05 METHODS AND COMPOSITIONS FOR INHIBITING INFLAMMATION AND ANGIOGENESIS JP National Stage 10-519747 Abandoned
NIDDK E-074-1998-0-US-01 Methods for Reducing Ischemic Injury of the Heart VIA the Sequential Administration of Momophosphoryl Lipid A and Adenosine Receptor Agents US 60/062,737 Abandoned
NIAID E-222-1997-0-US-01 FUNCTIONAL PROMOTER FOR CCR5 US 60/065,934 Abandoned
NCI E-231-1995-1-AU-14 METHODS OF IDENTIFYING PATIENTS HAVING AN ALTERED IMMUNE STATUS AU DIV 42829/97 Abandoned
NIAID E-072-1993-0-US-04 CLONING AND EXPRESSION OF PLASMODIUM FALCIPARUM TRANSMISSION-BLOCKING TARGET ANTIGEN, PFS230 US DIV 08/954,441 6316000 Abandoned PDF
NIDDK E-245-1992-0-US-04 ARALKYL DIAZABICYCLOALKANE DERIVATIVES FOR CNS DISORDERS US DIV 08/954,284 5958920 Abandoned PDF
NIMH E-121-1995-1-US-01 SUCEPTIBILITY AND RESISTANCE GENES FOR BIPOLAR AFFECTIVE DISORDER US 60/062,924 Abandoned
NIDDK E-174-1992-1-US-03 Chimeric Molecules Targeted to Viral RNAS US DIV 08/950,196 6271369 Abandoned PDF
NIDDK E-073-1998-0-US-01 METHODS AND COMPOSITIONS FOR REDUCING ISCHEMIC INJURY OF THE HEART BY ADMINISTERING ADENOSINE RECEPTOR AGONISTS AND ANTAGONISTS US 60/061,716 Abandoned
NCI E-193-1997-0-US-01 RECOMBINANT ADENOVIRAL TARGETING VECTOR US 60/061,587 Abandoned
NCI E-099-1996-0-US-01 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) US 60/061,589 Abandoned
NCI E-093-1993-0-AU-05 NOVEL IMMUNOTHERAPEUTIC METHODS AND VACCINES AU National Stage 40024/97 Abandoned
NCI E-196-1992-5-JP-07 POLYSACCHARIDE-BOUND NITRIC OXIDE-NUCLEOPHILE ADDUCTS JP DIV 2020-10-28 Abandoned
NIDDK E-003-1995-0-CA-11 PREPARATION OF CHIRAL 5-AMINOCARBONYL-5H-DIBENZO[A,D]CYCLOHEPTEN-5, 10-IMINES BY OPTICAL RESOLUTION CA National Stage 2217877 Abandoned
NIDDK E-289-1997-0-US-01 METHOD OF PREVENTING NEPHROTOXICITY CAUSED BY CYCLOSPORINS US 60/062,947 Abandoned
NIDCR E-127-1995-2-PCT-01 ISOLATION AND USE OF TISSUE GROWTH-INDUCING FRZB PROTEIN PCT PCT COMB PCT/US1997/018362 Expired
NCI E-265-1997-0-US-01 NOVEL HUMAN CANCER ANTIGEN, CAG-3 AND GENE ENDOCING SAME US 60/061,428 Abandoned
NIMH E-012-1999-0-US-01 LONG CIRCULATING PHAGE VECTORS US 60/061,447 Abandoned
NIMH E-011-1999-0-US-01 DIRECT USE OF TISSUE TO ISOLATE ANTI-HDS MODIFIED PHAGE US 60/061,446 Abandoned
NIAID E-221-1997-0-US-01 CHIMERIC VACCINE AGAINST TICK-BORNE ENCEPHALITIS VIRUS US 60/061,441 Abandoned
NCI E-072-1995-0-US-02 SELECTIVE PREVENTION OF ORGAN INJURY IN SEPSIS AND SHOCK USING SELECTION RELEASE OF NITRIC OXIDE IN VULNERABLE ORGANS US DIV 08/942,896 5814656 Expired PDF
NCI E-210-1995-2-PCT-02 No_Patent_Title PCT PCT PCT/US97/17714 Abandoned
NCI E-059-1996-0-PCT-02 INHIBITION OF HIV REPLICATION USING SOLUBLE TAT PEPTIDE ANALOGS PCT PCT PCT/US1997/017704 Expired
NIMH E-178-1996-1-US-01 THERAPEUTIC USE OF PHAGE EXPRESSING TOXIN-BINDING AND/OR CYTOKINE- BINDING PROTEINS US 60/060,881 Abandoned
NIMH E-178-1996-2-US-01 DELETION OF LYSOGENY GENES AND TOXIN GENES FROM BACTERIOPHAGE USED IN THE EPIDEMIOLOGIC CONTROL OF BACTERIAL ILLNESS US 60/060,879 Abandoned
NIAID E-102-1996-0-PCT-02 PFS25-28 FUSION AS A MALARIA TRANSMISSION BLOCKING VACCINE PCT PCT PCT/US1997/017666 Abandoned
NCI E-103-1997-0-US-01 2-ALKOXY ESTRADIOL ANALOGS: ANTIANGIOGENIC AND ANTICANCER AGENTS US ORD 60/059,916 Abandoned
NCI E-093-1996-3-EP-19 O2-SUBSTITUTED 1-[(2-CARBOXYLATO) PYRROLIDIN -1-YL] DIAZEN-1-IUM-1, 2-DIOLATES EP DIV 10010885.1 Expired
NCI E-093-1996-3-CA-20 O2-Glycosylated 1-Substituted Diazen-1-Um-1,2-Diolates CA DIV 2814748 Expired
NCI E-093-1996-3-EP-08 O2-ARYL SUBSTITUTED DIAZENIUMDIOLATES EP DIV 04009529.1 Expired
NCI E-093-1996-3-CA-18 O2-Glycosylated 1-Substituted Diazen-1-Um-1,2-Diolates CA DIV 2705474 Expired
NCI E-093-1996-3-CA-04 O2-ARYL SUBSTITUTED DIAZENIUMDIOLATES CA National Stage 2266908 Expired
NCI E-093-1996-3-JP-05 O2-ARYL SUBSTITUTED DIAZENIUMDIOLATES JP National Stage 515924/1998 Expired
NCI E-093-1996-3-DE-10 O2-ARYL SUBSTITUTED DIAZENIUMDIOLATES DE EP 97944471.8 Expired
NCI E-093-1996-3-FR-11 O2-ARYL SUBSTITUTED DIAZENIUMDIOLATES FR EP 97944471.8 Expired
NCI E-093-1996-3-CH-14 O2-ARYL SUBSTITUTED DIAZENIUMDIOLATES CH EP 97944471.8 Expired
NCI E-093-1996-3-BE-15 O2-ARYL SUBSTITUTED DIAZENIUMDIOLATES BE EP 97944471.8 Expired
NCI E-093-1996-3-IT-13 O2-ARYL SUBSTITUTED DIAZENIUMDIOLATES IT EP 97944471.8 Expired
NCI E-093-1996-3-IE-12 O2-ARYL SUBSTITUTED DIAZENIUMDIOLATES IE EP 97944471.8 Expired
NCI E-093-1996-3-EP-02 O2-ARYL SUBSTITUTED DIAZENIUMDIOLATES EP National Stage 97944471.8 Expired
NCI E-093-1996-3-GB-09 O2-ARYL SUBSTITUTED DIAZENIUMDIOLATES GB EP 97944471.8 Expired
NCI E-093-1996-3-AU-03 O2-ARYL SUBSTITUTED DIAZENIUMDIOLATES AU National Stage 45957/97 Expired
NCI E-093-1996-3-PCT-01 O2-ARYLATED OR O2-GLYCOSYLATED 1-SUBSTITUTED DIAZEN-1-IUM-1,2-DIOLATES AND O2-SUBSTITUTED 1-[(2-CARBOXYLATO)PYRROLIDIN-1-YL]DIAZEN-1-IUM ... PCT PCT COMB PCT/US1997/017267 Expired
NIAID E-179-1997-1-US-01 METHOD FOR INHIBITION OF HIV-1 REPLICATION US 60/060,124 Abandoned
NCI E-265-1994-1-US-01 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF TUMOR GENE INT6 US CIP 08/875,847 6255105 Abandoned PDF
NHLBI E-172-1997-0-US-02 METHOD FOR EXTRACTING DEFORMATIONS FROM VELOCITY-ENCODED MAGNETIC RESONANCE IMAGES OF THE HEART US ORD 08/937,725 6031374 Expired PDF
NEI E-078-1997-0-US-01 ANIMAL MODEL FOR AGE-RELATED MACULAR DEGENERATION AND METHODS FOR USE THEREOF US 60/060,045 Abandoned
NIAID E-101-1995-1-US-02 ISOLATED EPSTEIN-BARR VIRUS BZLF2 PROTEINS THAT BIND MHC CLASS II BETA CHAINS US DIV 08/936,854 5925734 Expired PDF
NHGRI E-135-1996-0-PCT-02 RETROVIRAL PACKAGING CASSETTES AMPLIFIED IN THE CYTOPLASM BY AUTOCATALYTIC TOGAVIRUS VECTORS PCT PCT PCT/US1997/017049 Expired